Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients (Q40610269)

22 September 2017

Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients (English)

1 reference

22 September 2017

0 references

Stephan Schmidt

1

1 reference

22 September 2017

Edin Moric

2

1 reference

22 September 2017

Martina Schmidt

3

1 reference

22 September 2017

Magdalena Sastre

4

1 reference

22 September 2017

Douglas L Feinstein

5

1 reference

22 September 2017

Michael T Heneka

6

1 reference

22 September 2017

4 December 2003

1 reference

Journal of Leukocyte Biology

22 September 2017

1 reference

22 September 2017

75

1 reference

22 September 2017

3

1 reference

22 September 2017

478-485

1 reference

Immunological aspects of demyelinating diseases

22 September 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0803402

21 January 2018

Identifiers

DOI

10.1189/JLB.0803402

1 reference

22 September 2017

1 reference